Squadron Capital LLC - Sep 20, 2022 Form 4 Insider Report for ORTHOPEDIATRICS CORP (KIDS)

Role
10%+ Owner
Signature
/s/ David R. Pelizzon, President of Squadron Capital LLC
Stock symbol
KIDS
Transactions as of
Sep 20, 2022
Transactions value $
$458
Form type
4
Date filed
9/22/2022, 07:34 AM
Previous filing
Aug 15, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KIDS Common Stock Exercise of in-the-money or at-the-money derivative security $458 +1.53M +28.36% $0.00* 6.9M Sep 20, 2022 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KIDS Warrants (right to buy) Exercise of in-the-money or at-the-money derivative security $0 +1.53M $0.00* 0 Sep 20, 2022 Common Stock 1.53M $0.00 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Squadron Capital LLC beneficially owns shares of the Issuer's common stock with a market value in excess of the notification threshold of the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (the "HSR Act"). The warrants could not be exercised until the expiration of all applicable HSR Act waiting periods or the exercise otherwise becomes exempt from the notification requirements thereunder. On September 19, 2022, the waiting period under the HSR Act expired. Once the warrants became exercisable, Squadron Capital LLC was obligated to exercise them within five (5) business days.
F2 These securities are held directly by Squadron Capital LLC. Squadron Capital Holdings LLC is the controlling member of Squadron Capital LLC.